The global lung cancer therapeutics market was valued at USD 31.92 Billion in 2024 and is projected to reach USD 95.65 Billion by 2034, growing at a CAGR of 11.60%. Growth is fueled by rising lung cancer prevalence, increasing adoption of targeted therapies, advancements in immunotherapy, and expanding healthcare investments worldwide. https://www.expertmarketresearch.com/reports/lung-cancer-therapeutics-market